The invalidation of MuRF1 in humans mostly impacts cardiac function with no or moderate alterations on skeletal muscles as only hypertrophic cardiomyopathy or transient ischemic attack helped reveal these mutations. This evidence concerns the gene TRIM63 and hypertrophic cardiomyopathy.